1 min read
Capital Roadmaps That Survive Approval
Lessons from guiding multi-billion dollar pharma investments through governance gauntlets.

Narrative Beats Numbers Alone
Executive committees fund clarity. Translate engineering trade-offs into stories about patient impact, supply resilience, and workforce capability.
Model Optionality
Scenario modelling should not be a hidden spreadsheet. Visualize the switching costs between alternatives so decision-makers can course-correct without political drama.
Close the Loop
Institutionalize post-approval reviews that focus on learning, not blame. It is the fastest way to future-proof capital strategy.